A recent study reported reduced early-phase insulin secretion in ALS patients, and autopsies of the pancreas β-cells from sporadic ALS patients demonstrated a loss of nuclear TDP-43, a key neuropathological hallmark in ALS, although there was no reduction in β-cell mass [76]. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.